CPRX vs. CL

In the year-to-date period, CPRX achieves a 12.36% return, which is significantly higher than CL's 4.47% return. Over the past 10 years, CPRX has outperformed CL with an annualized return of 20.83%, while CL has yielded a comparatively lower 5.62% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Colgate-Palmolive Company (CL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CPRX Sharpe Ratio is 1.43, which is higher than the CL Sharpe Ratio of 0.41. The chart below compares the historical Sharpe Ratios of CPRX and CL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

CPRX has not paid dividends to shareholders, while CL's dividend yield for the trailing twelve months is around 2.15%.

The maximum CPRX drawdown since its inception was -94.25%, which is greater than CL's maximum drawdown of -58.90%. Use the drawdown chart below to compare losses from any high point for CPRX and CL. For additional features, visit the drawdowns tool.

Catalyst Pharmaceuticals, Inc. (CPRX) has a higher volatility of 14.53% compared to Colgate-Palmolive Company (CL) at 8.54%. This indicates that CPRX's price experiences larger fluctuations and is considered to be riskier than CL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and Colgate-Palmolive Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.